Haite Biotech: Announcement on proposed asset impairment preparations for 2024
Haite Biotech: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products
Haite Biotech: Announcement on changes in the company\'s pharmaceutical production license
Haite Biotech: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the Company\'s 2024 Second Extraordinary General Meeting of Shareholders
Haite Biotech: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Haite Biotech: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products
Haite Biotech: Announcement on the company\'s participation in the national centralized procurement of drugs to be selected
Haite Biotech: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Haite Biotech: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the Company\'s 2024 First Extraordinary General Meeting of Shareholders
Haite Biotech: Announcement on the completion of the general election of the board of directors and the board of supervisors and the appointment of senior management and securities affairs representatives
Haite Biotech: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Haite Biotech: Announcement on the inclusion of the company\'s injectable epneamin in the national medical insurance catalogue
Haite Biotech: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Haite Biotech: Opinions of the 8th Board Nomination Committee on the Eligibility of Independent Director Candidates for the 9th Board of Directors
Haite Biotech: Announcement on the Election of Staff Representative Supervisors for the 9th Board of Supervisors
Haite Biotech: Announcement on the election of the board of directors for a new term
Haite Biotech: Announcement on the election of the Board of Supervisors for a new term
Haite Biotech: Announcement on the use of idle funds raised and own funds for cash management
Haite Biotech: Prompt announcement for disclosure of the report for the third quarter of 2024
Haite Biotech: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products